Evaluation of Executive Function With Virtual Reality Among People With Schizophrenia
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
This Cross-sectional Study Included Patients that diagnosed with schizophrenia, aged 18-55, 20 of which hospitalized in mental health department and 20 in medical follow-up. Different test will be administered, in two or three sessions, to evaluate cognitive ability, function ability and participation. The results of the VIS shopping task performance (statically \& dynamically) and its correlation with the cognitive and function tests as well as the participation questionnaire will be examined. These findings will indicate whether the shopping task is valid to assess executive functions for people with schizophrenia and whether it is ecologically valid.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Jul 2017
Shorter than P25 for not_applicable schizophrenia
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2017
CompletedFirst Posted
Study publicly available on registry
May 9, 2017
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedMay 9, 2017
May 1, 2017
1 year
April 1, 2017
May 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified 4 item test
"buy" 4 items with budget constraints, using the VIS
through study completion, an average of 1 year
Secondary Outcomes (5)
Revised Observed Tasks of Daily Living (OTDL-R)
through study completion, an average of 1 year
Executive Function Performance Test (EFPT)
through study completion, an average of 1 year
Trail Making Test A & B (TMT)
through study completion, an average of 1 year
The positive and negative syndrome scale (PANSS)
through study completion, an average of 1 year
Adults Subjective Assessment of Participation
through study completion, an average of 1 year
Study Arms (2)
Hospitalization patients
EXPERIMENTALpatients in psychiatric hospitalization will take part in tests at Virtual Reality - Virtual Interactive Supermarket environment (diagnosis)
Ambulatory patients
EXPERIMENTALpatients being treated in a clinic will take part in tests at Virtual Reality - Virtual Interactive Supermarket environment (diagnosis)
Interventions
SeeMe is a PC based, innovative, comprehensive, clinician-controlled exercise and diagnostic system. SeeMe is designed to aid the rehabilitation process, and track patients' progress. Virtual Interactive Supermarket- one of the SeeMe Tasks, the user need to buy products by according to specific instruction
Eligibility Criteria
You may qualify if:
- Schizophrenia or Scizoeffective diagnosis, Hebrew language proficiency, three weeks of anti-psychotic drug treatment
You may not qualify if:
- score of under 70 in the 3MS (screen test), physical disability, neurological diagnosis (ex. dementia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of psychiatry
Study Record Dates
First Submitted
April 1, 2017
First Posted
May 9, 2017
Study Start
July 1, 2017
Primary Completion
July 1, 2018
Study Completion
August 1, 2018
Last Updated
May 9, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share